_version_ 1783716534314598400
author Imafuku, Tadashi
Watanabe, Hiroshi
Oniki, Kentaro
Yoshida, Akira
Kato, Hiromasa
Nakano, Takehiro
Tokumaru, Kai
Fujita, Issei
Arimura, Nanaka
Maeda, Hitoshi
Sakamoto, Yuki
Kondo, Nozomi
Morita, Ayami
Saruwatari, Junji
Tanaka, Motoko
Matsushita, Kazutaka
Wada, Takashi
Fukagawa, Masafumi
Otagiri, Masaki
Fitzgerald, Michael L.
Jinnouchi, Hideaki
Maruyama, Toru
author_facet Imafuku, Tadashi
Watanabe, Hiroshi
Oniki, Kentaro
Yoshida, Akira
Kato, Hiromasa
Nakano, Takehiro
Tokumaru, Kai
Fujita, Issei
Arimura, Nanaka
Maeda, Hitoshi
Sakamoto, Yuki
Kondo, Nozomi
Morita, Ayami
Saruwatari, Junji
Tanaka, Motoko
Matsushita, Kazutaka
Wada, Takashi
Fukagawa, Masafumi
Otagiri, Masaki
Fitzgerald, Michael L.
Jinnouchi, Hideaki
Maruyama, Toru
author_sort Imafuku, Tadashi
collection PubMed
description
format Online
Article
Text
id pubmed-8247487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-82474872022-06-01 Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes Imafuku, Tadashi Watanabe, Hiroshi Oniki, Kentaro Yoshida, Akira Kato, Hiromasa Nakano, Takehiro Tokumaru, Kai Fujita, Issei Arimura, Nanaka Maeda, Hitoshi Sakamoto, Yuki Kondo, Nozomi Morita, Ayami Saruwatari, Junji Tanaka, Motoko Matsushita, Kazutaka Wada, Takashi Fukagawa, Masafumi Otagiri, Masaki Fitzgerald, Michael L. Jinnouchi, Hideaki Maruyama, Toru Diabetes Care e-Letters: Observations American Diabetes Association 2021-06 2021-04-26 /pmc/articles/PMC8247487/ /pubmed/33905348 http://dx.doi.org/10.2337/dc20-3003 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Observations
Imafuku, Tadashi
Watanabe, Hiroshi
Oniki, Kentaro
Yoshida, Akira
Kato, Hiromasa
Nakano, Takehiro
Tokumaru, Kai
Fujita, Issei
Arimura, Nanaka
Maeda, Hitoshi
Sakamoto, Yuki
Kondo, Nozomi
Morita, Ayami
Saruwatari, Junji
Tanaka, Motoko
Matsushita, Kazutaka
Wada, Takashi
Fukagawa, Masafumi
Otagiri, Masaki
Fitzgerald, Michael L.
Jinnouchi, Hideaki
Maruyama, Toru
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title_full Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title_fullStr Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title_full_unstemmed Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title_short Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
title_sort cysteinylated albumin as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes
topic e-Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247487/
https://www.ncbi.nlm.nih.gov/pubmed/33905348
http://dx.doi.org/10.2337/dc20-3003
work_keys_str_mv AT imafukutadashi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT watanabehiroshi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT onikikentaro cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT yoshidaakira cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT katohiromasa cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT nakanotakehiro cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT tokumarukai cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT fujitaissei cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT arimurananaka cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT maedahitoshi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT sakamotoyuki cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT kondonozomi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT moritaayami cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT saruwatarijunji cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT tanakamotoko cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT matsushitakazutaka cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT wadatakashi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT fukagawamasafumi cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT otagirimasaki cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT fitzgeraldmichaell cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT jinnouchihideaki cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes
AT maruyamatoru cysteinylatedalbuminasapotentialbiomarkerfortheprogressionofkidneydiseaseinpatientswithtype2diabetes